In sharp contrast, the HR (HR = 1.85 (1.19–2.88)) was greater in TNBC, indicating that a high TSP1 mRNA expression level in tumor samples can be considered as an independent bad prognosis biomarker in TNBC, but not in all breast cancers. The gene discussed is THBS1; the disease is breast carcinoma.